It’s been quite a slow news week! Most folks are apparently too busy grilling burgers and performing cannonballs off diving boards to release any items of interest.
Here are a few bits scrounged from news sources:
Shire gearing up for Vyvanse (ADHD treatment) launch in the U.S.
AstraZeneca to do the slash job with Medimmune staff.
Novartis and the vaccine business – a good long-term strategy.
J&J gets great results with a new experimental HIV drug.
A drug to help selectively wipe out memories? At first blush, I’ve got mixed feelings about this kind of stuff. It doesn’t take much imagination to think of scenarios where something like this could be used for non-medical purposes…
InVentiv Health buys Sanofi-Aventis, I.B.M, and Lithuania. OK, I made that up. But they do keep acquiring somewhat smaller targets.
Impactiviti blog 